{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:48:57Z","timestamp":1776721737038,"version":"3.51.2"},"reference-count":3,"publisher":"American College of Physicians","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.7326\/annals-26-00955-jc","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:00:31Z","timestamp":1775509231000},"page":"JC38","source":"Crossref","is-referenced-by-count":0,"title":["In patients with painful diabetic neuropathy, pregabalin does not differ from duloxetine for pain"],"prefix":"10.7326","volume":"179","author":[{"given":"Margretta","family":"Diemer","sequence":"first","affiliation":[{"name":"Walter Reed National Military Medical Center, Bethesda, Maryland, USA (M.D.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ANNALS-26-00955-R1","unstructured":"Higgins JPT, Thomas J, Chandler J, et al, eds.\n                      Chapter 10: analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane; 2024. Accessed at www.cochrane.org\/handbook on 22 Jan 2026."},{"key":"ANNALS-26-00955-R2","unstructured":"U.S Food and Drug Administration.\n                      FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). 19 Dec 2019. Accessed at www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin on 22 Jan 2026."},{"key":"ANNALS-26-00955-R3","unstructured":"U.S. Drug Enforcement Administration.\n                      Drug scheduling. Accessed at www.dea.gov\/drug-information\/drug-scheduling on 22 Jan 2026."}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-26-00955-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-26-00955-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:03:13Z","timestamp":1776718993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-26-00955-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.7326\/ANNALS-26-00955-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-26-00955-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}